6. Glycemic Targets: Standards of Medical Care in Diabetes—2021
The DOI matches its Crossref record; 117 of the 118 references it cites were found in a registry or an index.
Abstract
The American Diabetes Association (ADA) “Standards of Medical Care in Diabetes” includes the ADA's current clinical practice recommendations and is intended to provide the components of diabetes care, general treatment goals and guidelines, and tools to evaluate quality of care. Members of the ADA Professional Practice Committee, a multidisciplinary expert committee (https://doi.org/10.2337/dc21-SPPC), are responsible for updating the Standards of Care annually, or more frequently as warranted. For a detailed description of ADA standards, statements, and reports, as well as the evidence-grading system for ADA's clinical practice recommendations, please refer to the Standards of Care Introduction (https://doi.org/10.2337/dc21-SINT). Readers who wish to comment on the Standards of Care are invited to do so at professional.diabetes.org/SOC.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“These findings have informed clinical practice guidelines and policy, which now recommend that SMBG not be used routinely in this group (21–26).”
In the citing paper
“While the drug manufacturer is currently offering a savings card program for some patients for whom pricing is a barrier, payor coverage for tirzepatide will likely be a barrier to patient use, especially before tirzepatide has been officially recognized as a standard of care in professional guidelines. 2”
From Tirzepatide: Clinical review of the twincretin injectable (2023) · cites this paper as [2]
Citations
Cites
(1993) · New England Journal of Medicine · doi:10.1056/nejm199309303291401 · Cited by 24,667
Stratton, I. M. (2000) · BMJ · doi:10.1136/bmj.321.7258.405 · Cited by 9,059
Effects of Intensive Glucose Lowering in Type 2 Diabetes
(2008) · New England Journal of Medicine · doi:10.1056/nejmoa0802743 · Cited by 7,888
10-year follow-up of intensive glucose control in type 2 diabetes
Holman, R. R., Paul, S. K., Bethel, M. A., Matthews, D. R., & Neil, H. A. W. (2008) · New England Journal of Medicine · doi:10.1056/nejmoa0806470 · Cited by 7,751 · cited 2×
“33% with metformin as initial pharmacotherapy) and in all-cause mortality (13% and 27%, respectively) (33).”
BackgroundIntensive blood glucose control and vascular outcomes in patients with type 2 diabetes
(2008) · New England Journal of Medicine · doi:10.1056/nejmoa0802987 · Cited by 7,397
Intensive diabetes treatment and cardiovascular disease in patients with type 1 diabetes
(2005) · New England Journal of Medicine · doi:10.1056/nejmoa052187 · Cited by 5,138
Glucose control and vascular complications in veterans with type 2 diabetes
Duckworth, W., Abraira, C., Moritz, T., Reda, D., Emanuele, N., Reaven, P. D., Zieve, F. J., Marks, J., Davis, S. N., Hayward, R., et al. (2009) · New England Journal of Medicine · doi:10.1056/nejmoa0808431 · Cited by 4,762
Battelino, T., Danne, T., Bergenstal, R. M., Amiel, S. A., Beck, R., Biester, T., Bosi, E., Buckingham, B. A., Cefalu, W. T., Close, K. L., et al. (2019) · Diabetes Care · doi:10.2337/dci19-0028 · Cited by 4,237
Research works printed but not linked: 1
- Dicembrini, Impact of technology on glycemic control in type 2 diabetes: a meta-analysis of randomized trials on continuous glucose monitoring and continuous subcutaneous insulin infusion, Diabetes Obes Metab
Cited by
Items 401–500 of 846
Diabetes Screening and Monitoring Among Older Mexican-Origin Populations in the U.S.
Datta, R., Lucas, J., Marino, M., Aceves, B., Ezekiel-Herrera, D., Guzmán, C. E. V., Giebultowicz, S., Chung‐Bridges, K., Kaufmann, J., Bazemore, A., et al. (2022) · Diabetes Care · doi:10.2337/dc21-2483 · Cited by 6
Zhou, B.-Y., Zhang, Q., Hu, Y., Wang, L., Zhang, J., Cong, H., & Wang, L. (2022) · Nutrition Metabolism and Cardiovascular Diseases · doi:10.1016/j.numecd.2022.05.013 · Cited by 8
Buzzetti, R., Fadini, G. P., Nicolucci, A., Larosa, M., Rossi, M. C., Cucinotta, D., Gabellieri, E., Mauro, A., Alberto, M., del Grappa, B., et al. (2022) · Nutrition Metabolism and Cardiovascular Diseases · doi:10.1016/j.numecd.2022.06.003 · Cited by 7
Matsusaka, Y., Chen, X., Arias-Loza, P.-A., Werner, R. A., Nose, N., Sasaki, T., Rowe, S. P., Pomper, M. G., Lapa, C., & Higuchi, T. (2022) · Molecular Imaging · doi:10.1155/2022/4635171 · Cited by 7
“Moreover, we investigated healthy animals, and additional experiments could be conducted in renal impaired and/or diabetic ZDF fa/fa rats [20], thereby closer mimicking diabetic patients with preexisting renal comorbidities that are prone to treatment failure under SGLT inhibitors [17].”
BackgroundMontanari, V. A., Gabbay, M. A. L., & Dib, S. A. (2022) · Diabetology & Metabolic Syndrome · doi:10.1186/s13098-022-00903-z · Cited by 6
Almazrouei, R. A., Sharma, C., Afandi, B. O., Aldahmani, K. M., Aburawi, E. H., Beshyah, S., ElGhazali, G. E., Yafei, Z. A., Al‐Rifai, R. H., & Alkaabi, J. (2022) · PLoS ONE · doi:10.1371/journal.pone.0264545 · Cited by 7
Diabetic retinopathy as a predictor for peripheral compression neuropathies, a registry-based study
Olsson, C., Rydberg, M., & Zimmerman, M. (2022) · PLoS ONE · doi:10.1371/journal.pone.0275598 · Cited by 7
Cui, X., Li, J., Yang, Y., Wu, J., Xu, H., Yu, Y., & Qin, G. (2022) · Journal of Diabetes · doi:10.1111/1753-0407.13329 · Cited by 5
Prevalence and management of type 2 diabetes among Chinese Americans
Niu, L., Li, Y., Hwang, W., Song, G., & Xie, B. (2023) · Ethnicity and Health · doi:10.1080/13557858.2023.2179020 · Cited by 6
Cai, L. Y., Tanase, C., Anderson, A. W., Patel, N., Lee, C. A., Jones, R. S., LeStourgeon, L. M., Mahon, A., Taki, I., JUVERA, J. V., et al. (2023) · American Journal of Neuroradiology · doi:10.3174/ajnr.a7895 · Cited by 6
Shestakova, M. V., Kvasnikov, B. B., Erina, E. E., Isachenko, E., & Andreev, A. (2023) · BMJ Open Diabetes Research & Care · doi:10.1136/bmjdrc-2022-003290 · Cited by 8
Alhassan, H. A., Akunor, H., Howard, A., Donohue, J. P., Kainat, A., Onyeaka, H., & Aiyer, A. (2023) · Circulation Cardiovascular Quality and Outcomes · doi:10.1161/circoutcomes.122.009609 · Cited by 9
“21 ; and obesity as a body mass index of ≥ 30 kg/m².”
BackgroundMajd, Z., Mohan, A., Fatima, B., Johnson, M. L., Essien, E. J., & Abughosh, S. (2023) · Patient Education and Counseling · doi:10.1016/j.pec.2023.108073 · Cited by 7
Zhang, F., Chen, X., Liu, X., Shen, X., Liu, T., Zeng, F., & Jin, R. (2024) · Frontiers in Endocrinology · doi:10.3389/fendo.2023.1208202 · Cited by 7
Swift, C., Frazer, M., Gronroos, N. N., Sargent, A., Leszko, M., Buysman, E. K., Alvarez, S., Dunn, T. J., Noone, J. M., & Guevarra, M. (2024) · Diabetes Obesity and Metabolism · doi:10.1111/dom.15516 · Cited by 7
Mauricio, D., Gourdy, P., Bonadonna, R. C., Freemantle, N., Bigot, G., Mauquoi, C., Ciocca, A., Bonnemaire, M., & Müller‐Wieland, D. (2021) · Diabetes Therapy · doi:10.1007/s13300-021-01031-z · Cited by 8
Jeong, M. (2021) · Healthcare · doi:10.3390/healthcare9081049 · Cited by 7
Li, G., Wang, S., Xiong, Y., Gu, H., Jiang, Y., Yang, X., Wang, C., Wang, C., Li, Z., & Zhao, X. (2022) · CNS Neuroscience & Therapeutics · doi:10.1111/cns.13972 · Cited by 6
Scarton, L. J., Nelson, T., Yao, Y., Segal, R., Donahoo, W. T., Goins, R. T., DeVaughan-Circles, A., Manson, S. M., & Wilkie, D. J. (2022) · JMIR Research Protocols · doi:10.2196/39193 · Cited by 5
“These values were selected based on Medicare definitions [40] and American Diabetes Association guidelines [31].”
Kim, S., Kim, G., & Kim, J. H. (2022) · Scientific Reports · doi:10.1038/s41598-022-24466-1 · Cited by 7
Benhamou, P., Adenis, A., Lablanche, S., Franc, S., Amadou, C., Penfornis, A., Kariyawasam, D., Beltrand, J., & Charpentier, G. (2023) · Journal of Diabetes Science and Technology · doi:10.1177/19322968231186976 · Cited by 6
“Additional data from post hoc analysis showed that the use of this algorithm was associated with an important decrease in TBR also in populations prone to hypoglycemia, 18 whereas it could prevent the increase of hypoglycemia risk related to physical activities.”
BackgroundMethodStewart, K. D., Matza, L. S., Patel, H., & Boye, K. S. (2023) · Journal of Patient-Reported Outcomes · doi:10.1186/s41687-023-00614-7 · Cited by 5
Ekpor, E., Akyirem, S., & Duodu, P. A. (2024) · PLOS Global Public Health · doi:10.1371/journal.pgph.0002835 · Cited by 9
“Given the evolving paradigm shift from NAFLD to MAFLD, research endeavors in Africa must adapt to encompass these changes to comprehensively grasp the spectrum of MAFLD and its impact on health in the African population.”
BackgroundSelf-reported periodontitis: A multiethnic community-based validation study
Goh, C. E., Chew, R. J. J., Lai, C. W. M., Seah, F., Lim, M., Febriana, E., Lee, M. H., Feng, J. K. T., Tan, K. S., Fu, J., et al. (2025) · Journal of Dentistry · doi:10.1016/j.jdent.2025.106294 · Cited by 5
Preoperative A1c and Postoperative Infection in Elective Hand Surgery
Schweitzer, T. P., & Peterson, S. L. (2022) · Hand · doi:10.1177/15589447211065493 · Cited by 7
Xu, J., Xue, Y., Chen, Q., Han, X., Cai, M., Tian, J., Jin, S., & Lu, H. (2022) · Frontiers in Medicine · doi:10.3389/fmed.2022.928825 · Cited by 8
Mengstie, M. A., Abebe, E. C., Dejenie, T. A., Seid, M. A., & Teshome, A. A. (2024) · Pan African Medical Journal · doi:10.11604/pamj.2024.47.7.37452 · Cited by 8
“…control: was defined as an HbA1c level ≥ 7% according to the American diabetes association (ADA) standards of medical care in diabetes 2021 recommendation [20]; 2) regular physical exercise: participants who purposively perform any kind of exercise for over 30 minutes at least 3 times per week.”
MethodLebbad, H., Désir, C., Vesin, A., Adenis, A., Charpentier, G., & Benhamou, P. (2024) · Journal of Diabetes Science and Technology · doi:10.1177/19322968241252366 · Cited by 7
“8,1,2 A previous report had identified patient age, sex, body mass index, duration of insulin pump treatment, glycated hemoglobin, and serum triacylglycerol concentrations as significant predictors of the total daily basal insulin infusion rate.”
Real-world use of medical therapy in moderate asymptomatic carotid stenosis
Bloch, R. A., Ellias, S. D., Caron, E., Prushik, S. G., Shean, K. E., & Conrad, M. F. (2024) · Journal of Vascular Surgery · doi:10.1016/j.jvs.2024.05.037 · Cited by 5
Safary, E., Lepeska, M., Beran, D., Ewen, M. A., Zhaparova, A., Rukare, J., Boulle, P., Perone, S. A., Makohliso, S. A., Pleus, S., et al. (2024) · PLoS ONE · doi:10.1371/journal.pone.0309062 · Cited by 7
The Use of Continuous Glucose Monitoring in Older People With Type 2 Diabetes
Rao, H., Fakourfar, N., Sun, C., & Lewis, J. (2021) · The Senior Care Pharmacist · doi:10.4140/tcp.n.2021.556 · Cited by 5
Obesity surgery in patients with end-stage organ failure: Is it worth it?
Billeter, A. T., Zumkeller, M., Brock, J. M., Herth, F. J. F., Zech, U., Zeier, M. G., Rupp, C., Wagenlechner, P., Mehrabi, A., & Müller-Stich, B. P. (2021) · Surgery for Obesity and Related Diseases · doi:10.1016/j.soard.2021.11.012 · Cited by 5
Wen, W., Huang, H., Lin, H.-C., Lo, W., Chen, S., & Lee, M. (2022) · Nutrients · doi:10.3390/nu14020320 · Cited by 5
Schwartz, J. L., Duan, D., Maruthur, N. M., & Pitts, S. I. (2022) · The Joint Commission Journal on Quality and Patient Safety · doi:10.1016/j.jcjq.2022.03.002 · Cited by 6
Wu, Y., Li, R., Zhang, Y., Long, T., Zhang, Q., & Li, M. (2022) · Biological Research For Nursing · doi:10.1177/10998004221115856 · Cited by 5
Li, L., Lip, G. Y. H., Li, S., Adachi, J. D., Thabane, L., & Li, G. (2022) · Cardiovascular Diabetology · doi:10.1186/s12933-022-01567-9 · Cited by 5
Antoniak-Pietrynczak, K., Zorena, K., Jaskulak, M., Hansdorfer-Korzon, R., Mrugacz, M., & Koziński, M. (2022) · Biomedicines · doi:10.3390/biomedicines10071730 · Cited by 7
Антонова, К. В., Лагода, О. В., & Tanashyan, M. М. (2022) · Diabetes Mellitus · doi:10.14341/dm12840 · Cited by 7
Kishimoto, I., & Ohashi, A. (2022) · Endocrines · doi:10.3390/endocrines3030043 · Cited by 5
Impact of cumulative hyperglycemic burden on the pancreatic cancer risk: A nationwide cohort study
Koo, D., Han, K., & Park, C. (2022) · Diabetes Research and Clinical Practice · doi:10.1016/j.diabres.2022.110208 · Cited by 6
Leng, Y., Fu, X., Qian, L., Li, Q., Gao, H., Xie, H., & Xie, C. (2022) · BMC Complementary Medicine and Therapies · doi:10.1186/s12906-022-03813-9 · Cited by 5
Wu, H., Lau, E. S. H., Yang, A., Fan, B., Ronald, C. W., Kong, A. P. S., Chow, E., So, W., Chan, J. C. N., & Luk, A. O. Y. (2023) · Diabetes/Metabolism Research and Reviews · doi:10.1002/dmrr.3615 · Cited by 6
Khanal, M. K., Bhandari, P., Dhungana, R. R., Gurung, Y., Rawal, L. B., Pandey, G., Bhandari, M., Bhuiyan, R., Devkota, S. P., de Courten, M., et al. (2023) · Journal of Diabetes Investigation · doi:10.1111/jdi.13985 · Cited by 6
Messer, L. H., Bauza, C. E., Miller, K. M., Clements, M. A., DeSalvo, D. J., Sherr, J. L., Weinstock, R. S., Hood, K. K., & Laffel, L. M. (2023) · Pediatric Diabetes · doi:10.1155/2023/6906023 · Cited by 7
“people with type 1 diabetes (T1D), with less than 14%meeting the American Diabetes Association target of HbA1c< 7% (<53mmol/mol) [1, 2].”
Karthikeyan, A., Ramakrishna, M. P., Swamy, N. A., & Latha, A. T. (2024) · Annals of African Medicine · doi:10.4103/aam.aam_117_23 · Cited by 5
“[3] TIR is a CGM metric that reflects the amount of time a person’s glucose levels remain within a target range.”
Johansson, U., Gleissman, S. A., Lidén, M. K., Wickman, M., Gustafsson, B., & Sjöberg, S. (2024) · Heliyon · doi:10.1016/j.heliyon.2024.e29498 · Cited by 6
Diawara, A., Coulibaly, D. M., Fofana, F. G., Koné, D., Traore, M. A., Bazi, D. S., Kassogué, O., Sylla, D., Diabaté, O., Sangaré, M., et al. (2024) · Journal of Diabetes Mellitus · doi:10.4236/jdm.2024.142012 · Cited by 5
“HbA1c values below 7.0% were considered as adequate glycemic control as per the American Diabetes Association guidelines [28].”
MethodInfluentialUlambayar, B., Ghanem, A. S., Nguyen, C. M., Faludi, E. V., Móré, M., & Nagy, A. C. (2024) · Journal of Clinical Medicine · doi:10.3390/jcm13123561 · Cited by 5
“As the American Diabetes Association (ADA) guidelines suggest measuring HbA1C twice a year [25], DM management was categorized as adequate if HbA1c was assessed exactly twice a year; if it was measured less than twice a year or more, diabetes care was categorized as inadequate [26].”
BackgroundMukonda, E. E., van der Westhuizen, D. J., Dave, J. A., Cleary, S., Hannan, L., Rusch, J. A., & Lesosky, M. (2025) · BMC Endocrine Disorders · doi:10.1186/s12902-024-01816-w · Cited by 10
GRAF, S. F., Hofer, G., Hirschmann, R., Lehmann, R., & Cavelti‐Weder, C. (2025) · Diabetes Research and Clinical Practice · doi:10.1016/j.diabres.2025.112035 · Cited by 6
Madsen, N. J., Joyce, C., Vlasses, F. R., & Burkhart, L. (2021) · Journal of Interprofessional Care · doi:10.1080/13561820.2021.1941816 · Cited by 6
Factors associated with work ability in adults with diabetes
McCarthy, M. M., Yan, J., & Dickson, V. V. (2021) · Applied Nursing Research · doi:10.1016/j.apnr.2021.151478 · Cited by 5
Caballero, A. E., Nordstrom, B. L., Liao, B., Fan, L., Zhang, N., Fraeman, K. H., & Perez‐Nieves, M. (2021) · Journal of Diabetes and its Complications · doi:10.1016/j.jdiacomp.2021.108011 · Cited by 5
Brož, J., Campbell, M. D., Urbanová, J., Nunes, M. A., Brunerová, L., Rahelić, D., Žďarská, D. J., Taniwall, A., Brabec, M., Berka, V., et al. (2021) · Nutrients · doi:10.3390/nu13114165 · Cited by 7
Lin, Y. K., Richardson, C. R., Dobrin, I., Pop‐Busui, R., Piatt, G., & Piette, J. D. (2022) · JMIR Diabetes · doi:10.2196/36140 · Cited by 7
Gómez, A. M., Diana Cristina Henao, C., Rebolledo, M., Jaramillo, P., Múñoz, Ó., Laura María Niño, G., & Yepes, C. A. (2022) · Journal of Diabetes Science and Technology · doi:10.1177/19322968221108424 · Cited by 6
“Both the latest 2021 American Diabetes Association guidelines and the 2019 international consensus of clinical objectives for the interpretation of CGM recommend a TIR ≥ 70% as a therapeutic objective 13,23 based on two previous publications.”
BackgroundGaldino, G. A. M., Moura-Tonello, S. C. G., Linares, S. N., Milan‐Mattos, J. C., Spavieri, D. L., de Oliveira, S. M., Porta, A., Beltrame, T., & Catai, A. M. (2022) · Brazilian Journal of Medical and Biological Research · doi:10.1590/1414-431x2022e12150 · Cited by 5
Rimac, D. S., Bilić-Čurčić, I., Prpić-Kriẑevac, I., Schönberger, E., Centner, M. G., Barišić, M., & Canecki-Varžić, S. (2022) · Healthcare · doi:10.3390/healthcare10091792 · Cited by 7
Bernier, É., Lachance, A., Plante, A.-S., Lemieux, P., Amari, K. M., Weisnagel, S. J., Gagnon, C., Michaud, A., Tchernof, A., & Morisset, A. (2022) · Nutrients · doi:10.3390/nu14193999 · Cited by 8
Anumah, F. E., Lawal, Y., Reng, R. S., Omonua, O. S., Odumodu, K., Shuaibu, R., Itanyi, U. D., Abubakar, A. I., Kolade-Yunusa, H. O., David, Z. S., et al. (2023) · The Foot · doi:10.1016/j.foot.2023.101987 · Cited by 5
Taleb, N., Gingras, V., Cheng, R., Parent, V., Messier, V., Bovan, D., Shohoudi, A., Brazeau, A., & RABASA-LHORET, R. P. R. (2023) · Frontiers in Endocrinology · doi:10.3389/fendo.2023.1186680 · Cited by 6
Koga, M., Kameyama, M., & Okumiya, T. (2023) · Journal of Clinical Laboratory Analysis · doi:10.1002/jcla.24947 · Cited by 4
Assessment of Insulin Infusion Requirements in COVID-19-Infected Patients With Diabetic Ketoacidosis
Farzadfar, D., Gordon, C., Falsetta, K. P., Calder, T., Tsegaye, A., Kohn, N. E., & Schulman‐Rosenbaum, R. (2022) · Endocrine Practice · doi:10.1016/j.eprac.2022.05.006 · Cited by 5
Davidsen, L., Cichosz, S. L., Knoph, C. S., Larsen, I. M., Stæhr, P., Vestergaard, P., Jensen, M. H., Hartmann, B., Holst, J. J., Drewes, A. M., et al. (2025) · Diabetic Medicine · doi:10.1111/dme.70080 · Cited by 4
Dongling, N., Kang, Z., Juanling, S., Li, Z., Chang, W., Ting, L., Hongli, L., & Yanchun, Z. (2025) · Frontiers in Endocrinology · doi:10.3389/fendo.2025.1557166 · Cited by 7
Guzmán, G. E., Escobar, M. F., Arias‐Valderrama, O., Guerra, M. A., & Martínez, V. (2023) · International Journal of Environmental Research and Public Health · doi:10.3390/ijerph20095719 · Cited by 6
Liu, N., Heng, C., Cui, Y., Wu, D., Li, L., Bai, M., Guo, Y., Wang, W., & Zhang, Y. (2023) · Nutrition and Diabetes · doi:10.1038/s41387-023-00252-4 · Cited by 4
“Guidelines for diabetes management across different countries have emphasized the signi fi cance of dietary management in patients with T2DM [1, 6, 7].”
Chen, M., Liu, M., Pu, Y. D., Wu, J., Zhang, M., Tang, H., Kong, L., Guo, M., Zhu, K., Xie, Y., et al. (2024) · Frontiers in Public Health · doi:10.3389/fpubh.2024.1295531 · Cited by 8
“This significance was particularly pronounced among patients undergoing insulin therapy (41).”
BackgroundLisni, I., Latarissa, I. R., Andalusia, L. R., & Lestari, K. (2024) · Pharmacia · doi:10.3897/pharmacia.71.e123313 · Cited by 8
“A controlled FBG level was defined within the range of 70–110 mg/dL (American Diabetes Association 2021).”
BackgroundNumaguchi, R., Kurajoh, M., Hiura, Y., Imai, T., Morioka, T., Saito, M., Shiraishi, S., Emoto, M., & Nishiguchi, Y. (2022) · Journal of Diabetes Investigation · doi:10.1111/jdi.13845 · Cited by 5
Le, Y., Yang, K., Yang, J., Fu, W., Xiao, W., Wei, R., & Hong, T. (2022) · Diabetes Therapy · doi:10.1007/s13300-022-01310-3 · Cited by 4
Li, Y.-J., Chang, Y., Chou, Y., & Hsu, C. (2023) · Scientific Reports · doi:10.1038/s41598-023-33542-z · Cited by 7
Harvengt, A., Beckers, M., Boutsen, L., Costenoble, E., Brunelle, C., & Lysy, P. A. (2023) · Nutrients · doi:10.3390/nu15132957 · Cited by 4
Yu, X., Yang, Z., Wang, X., Sun, X., Shen, R., Li, H., & Zhang, M. (2024) · BMC Medical Informatics and Decision Making · doi:10.1186/s12911-024-02761-3 · Cited by 5
“It has been found that patients with continuous glucose monitors (CGM) do not need to be overly concerned about nocturnal hypoglycemia [6].”
Ferrario, C., Santini, S., Vionnet, N., Pasquier, J., Puder, J. J., Mantziari, S., & Favre, L. (2025) · Surgery for Obesity and Related Diseases · doi:10.1016/j.soard.2025.03.008 · Cited by 5
Jiang, W., Li, L., Wang, W., Liang, Y., Bai, X., Xu, Y., Guo, Q., Ge, L., Liang, J., Lü, B., et al. (2025) · Frontiers in Endocrinology · doi:10.3389/fendo.2025.1573963 · Cited by 5
Grassi, B. A., Onetto, M. T., Zapata, Y., Jofré, P., & Echeverría, G. (2021) · Diabetes & Metabolic Syndrome Clinical Research & Reviews · doi:10.1016/j.dsx.2021.03.017 · Cited by 6
Perez-Belmonte, L. M., Ricci, M., Sanz‐Cánovas, J., Cobos-Palacios, L., Lopez-Carmona, M. D., Ruiz-Moreno, M. I., Millán‐Gómez, M., Bernal-López, M. R., Jansen‐Chaparro, S., & Gómez‐Huelgas, R. (2021) · Journal of Clinical Medicine · doi:10.3390/jcm10092013 · Cited by 4
Resident opinions of diabetes management in training: a survey
Healy, A. M., Uhrig, J. L., Shubrook, J. H., Aung, N. L., & Sadhu, A. (2021) · Journal of Osteopathic Medicine · doi:10.1515/jom-2021-0035 · Cited by 5
Dwyer, P., Drinkwater, J. J., Fegan, P. G., Davis, W. A., & Davis, T. M. E. (2021) · International Journal of Medical Sciences · doi:10.7150/ijms.63381 · Cited by 5
Empfehlungen zur Diabetes-Behandlung mit automatischen Insulin-Dosierungssystemen
Berge, T. V. D., Biester, S., Biester, T., Buchmann, A.-K., Datz, N., Grosser, U., Kapitzke, K., Klusmeier, B., Remus, K., Reschke, F., et al. (2021) · Diabetologie und Stoffwechsel · doi:10.1055/a-1652-9011 · Cited by 5
Chevalier, N., Penfornis, A., Riveline, J., Chartier, F., Mitchell, B. D., Osumili, B., Spaepen, E., Snoek, F. J., Peyrot, M. F., & Benabbad, I. (2021) · Annales d Endocrinologie · doi:10.1016/j.ando.2021.11.003 · Cited by 4
Validación transcultural del HypoA-Q para medir conciencia de hipoglucemia en pacientes diabéticos
Algarra, A. J. C., Hernández‐Zambrano, S. M., Matamoros, F. A. S., Henao, D. C., Medina, A. M. G., & Hurtado-Barrera, D. E. (2022) · Revista Ciencia y Cuidado · doi:10.22463/17949831.3056 · Cited by 5
Raghavan, S., Warsavage, T. J., Liu, W. G., Raffle, K., Josey, K., Saxon, D. R., Phillips, L. S., Caplan, L., & Reusch, J. E. B. (2022) · Diabetes Care · doi:10.2337/dc21-2492 · Cited by 6
Measurement of erythrocyte creatine might be useful for diagnosing latent hemolysis
Ijima, H., Hiratani, K., Jinnnouchi, H., Ono, Y., Kameyama, M., Okumiya, T., & Koga, M. (2022) · Clinical Biochemistry · doi:10.1016/j.clinbiochem.2022.05.007 · Cited by 4
Alem, M. M. (2022) · Heliyon · doi:10.1016/j.heliyon.2022.e11549 · Cited by 6
Tan, C., Li, B., Xiao, L., Zhang, Y., Su, Y., & Ding, N. (2022) · Diabetes Metabolic Syndrome and Obesity · doi:10.2147/dmso.s386687 · Cited by 6
Widmer, A., Mercante, M. G., & Silver, H. J. (2022) · Nutrients · doi:10.3390/nu14235106 · Cited by 4
Jiang, J., Zhang, X., Zheng, D., Li, Y., Li, F. R., Wang, W., Ding, S., Zhang, J., Su, X., Zhai, Q., et al. (2023) · Journal of Endocrinological Investigation · doi:10.1007/s40618-023-02142-z · Cited by 6
Qiu, W., Cai, A., Zhiqiang, N., Wang, J.-B., Ou, Y., & Feng, Y. (2023) · Preventive Medicine · doi:10.1016/j.ypmed.2023.107608 · Cited by 4
Zhang, R.-T., Liu, Y., Lin, K., Jia, W., Wu, Q.-Y., Wang, J., & Bai, X. (2023) · Diabetology & Metabolic Syndrome · doi:10.1186/s13098-023-01177-9 · Cited by 4
Scarr, D., Lovblom, L. E., Ye, H., Liu, H., BAKHSH, A. M. K., Verhoeff, N. J., Wolever, T. M. S., Lawler, P. R., Sharma, K., Cherney, D. Z. I., et al. (2023) · Diabetes Research and Clinical Practice · doi:10.1016/j.diabres.2023.111031 · Cited by 4
Adamson, K., Gibb, F. W., McLaren, J. B., Min, T., Price, H. C., Sankaranarayanan, S., & Strzelecka, A. (2024) · Diabetes Therapy · doi:10.1007/s13300-024-01629-z · Cited by 5
Sia, H., Kor, C., Tu, S., Liao, P.-Y., & Chang, Y.-C. (2021) · PeerJ · doi:10.7717/peerj.11005 · Cited by 4
“A total of 24,473 patients with T2DM were enrolled in the Diabetes Care Management Program (DCMP) at the CCH Diabetes Care Center between January 2002 and December 2017.”
BackgroundInfluentialHRAMIAK, I. M., Gerstein, H. C., Leiter, L. A., Yale, J., BAJAJ, H. S., Stewart, J. A., Toutounji, M.-J., & Harris, S. B. (2022) · Diabetes Obesity and Metabolism · doi:10.1111/dom.14787 · Cited by 3
Hernández‐Vásquez, A., Barrenechea-Pulache, A., Bonifaz, A. P., Rojas‐Roque, C., & Gamboa-Unsihuay, J. E. (2022) · Preventive Medicine Reports · doi:10.1016/j.pmedr.2022.101884 · Cited by 5
Risco de glicemia instável em pessoas idosas com diabetes mellitus tipo 2
Stival, M. M., de Lima, L. R., da Costa, M. V. G., Volpe, C. R. G., Funghetto, S. S., & Pinho, D. L. M. (2022) · Revista de Enfermagem da UFSM · doi:10.5902/2179769271452 · Cited by 21
Davies, M. J., Rosenstock, J., Ali, A., Russell-Jones, D. L., Souhami, E., PALMER, K. D., Ji, C. F., Niemoeller, E., & SKOLNIK, N. (2021) · Diabetes Obesity and Metabolism · doi:10.1111/dom.14543 · Cited by 4
Influence of glycaemic control on macular thickness in diabetic retinopathy
Sharma, S., Karki, P., Joshi, S. N., & Parajuli, S. (2021) · Endocrinology Diabetes & Metabolism · doi:10.1002/edm2.308 · Cited by 9
Peprah, E. B., Jahan, Y., Danso‐Appiah, A., Abdul-Samed, A.-B., Mirzoev, T. N., Antwi, E., Balabanova, D., & Agyepong, I. A. (2024) · Systematic Reviews · doi:10.1186/s13643-024-02555-8 · Cited by 3
“Despite objections to the preference of HBA1c for diagnosing diabetes by some researchers based on the cost and biological variation [16], it is generally regarded as a reliable metric for glycaemic improvement in clinical trials [17].”
Background
Metadata
- Authors
- American Diabetes Association
- Corresponding author
- American Diabetes Association
- Venue
- Diabetes Care
- Publisher
- American Diabetes Association
- Published
- 2020-12-04
- Volume
- 44
- Issue
- Supplement_1
- Pages
- S73-S84
- ISSN
- 0149-5992 (ISSN-L)
- 1935-5548
- OpenAlex
- W4236126199
- Cited by
- 847
- References
- 118
- Citations by year
- 2026: 43 · 2025: 80 · 2024: 115 · 2023: 156 · 2022: 265 · 2021: 187 · 2020: 1
- FWCI
- 23.36
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Diabetes Care (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes Management and Research
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes Treatment and Management
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes Management and Education
- Keywords
- glycemic targets, diabetes management, clinical guidelines, quality of care, level of evidence, treatment goals
- MeSH terms
- Blood Glucose, Diabetes Mellitus, Endocrinology, Humans, Societies, Medical, Standard of Care
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.